Intermediate-Size Patient Population Expanded Access: Foralumab in Non-Active Secondary Progressive MS Patients
Clinical trial NCT06802328 · AVAILABLE
Trial details
- NCT number
- NCT06802328
- Sponsor
- Tiziana Life Sciences LTD
- Status
- AVAILABLE
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.